Are cancer stem cells the sole source of tumor?

Abstract

Tumors are believed to consist of a heterogeneous population of tumor cells originating from rare cancer stem cells (CSCs). However, emerging evidence suggests that tumor may also originate from non-CSCs. To support this viewpoint, we are here to present definitive evidence indicating that the number of tumorigenic tumor cells is greater than that of CSCs in tumor, and tumor can also derive from non-CSCs. To achieve this, an idealized mathematical model was employed in the present study and theoretical calculation revealed that non-CSCs could initiate the occurrence of tumor if their proliferation potential was adequate. Further, experimental studies demonstrated that 17.7%, 38.6% and 5.2% of tumor cells in murine B16 solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were potentially tumorigenic. Thus, based on the aforementioned findings, we propose that the scarce CSCs, if exist, are not the sole source of a tumor.

Keywords

cancer stem cells / mathematical model / colony culture / tumor formation / tumor therapy 2008131).

References

[1] PardalR, ClarkeMF, MorrisonSJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer, 2003, 3(12): 895-902

[2] BjerkvigR, TysnesBB, AboodyKS, et al.. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer, 2005, 5(11): 899-904

[3] RosenJM, JordanCT. The increasing complexity of the cancer stem cell paradigm. Science, 2009, 324(5935): 1670-1673

[4] SmithA. A glossary for stem-cell biology. Nature, 2006, 441(7097): 1060-1060

[5] O’BrienCA, PollettA, GallingerS, et al.. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123): 106-110

[6] MaccalliC, VolontèA, CimminielloC, et al.. Immunology of cancer stem cells in solid tumours. A review. Eur J Cancer, 2014, 50(6): 649-55

[7] SourisseauT, HassanKA, WistubaI, et al.. Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough?. J Thorac Oncol, 2014, 9(1): 7-17

[8] YamashitaT, WangXW. Cancer stem cells in the development of liver cancer. J Clin Invest, 2013, 123(5): 1911-1918

[9] NishikawaS, DewiDL, IshiiH, et al.. Transcriptomic study of dormant gastrointestinal cancer stem cells. Int J Oncol, 2012, 41(3): 979-984

[10] KellyPN, DakicA, AdamsJM, et al.. Tumor growth need not be driven by rare cae]s. Science, 2007, 317e](5836): 337

[11] QuintanaE, ShackletonM, SabelMS, et al.. Efficient tumour formation by single human melanoma cells. Nature, 2008, 456(7222): 593-598

[12] HeYF, LiuYK, LuHJ, et al.. Comparative proteomic analysis of primary mouse liver c-Kit-(CD45/TER119)-stem/progenitor cells. J Cell Biochem, 2007, 102(4): 936-946

[13] HeYF, ZhangGM, WangXH, et al.. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol, 2004, 173(9): 4919-4928

[14] CollaniE, DrägerK. . Binomial distribution handbook for scientists and engineers, 2001

[15] EnderlingH, HlatkyL, HahnfeldtP. Migration rules: tumours are conglomerates of self-metastases. Br J Cancer, 2009, 100(12): 1917-1925

[16] RooseT, NettiPA, MunnLL, et al.. Solid stress generated by spheroid growth estimated using a linear poroelasticity model small star, filled. Microvasc Res, 2003, 66(3): 204-212

[17] Al-HajjM1, WichaMS, Benito-HernandezA, et al.. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 2003, 100(7): 3983-3988

[18] AdamsJM, KellyPN, DakicA, et al.. Response to comment on “tumor growth need not be driven by rare cancer stem cells”. Science, 2007, 318(5857): 1722